MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5) is a member of the STE20-like serine/threonine kinase family that functions as an upstream regulator in MAPK signaling cascades 1. MAP4K5 demonstrates kinase activity toward AMP-activated protein kinase-related kinases (ARKs), phosphorylating all 14 ARKs both in vivo and in vitro 1. The protein appears to play important roles in cellular stress responses and cytoskeletal organization through the STE20 kinase pathway 2. In pancreatic ductal adenocarcinoma, MAP4K5 expression is decreased or lost in 77.1% of cases, correlating with loss of E-cadherin and suggesting involvement in epithelial-to-mesenchymal transition 3. Low MAP4K5 expression serves as an independent prognostic factor for reduced overall survival in stage II pancreatic cancer patients 3. The gene undergoes alternative splicing to produce isoform variants (V569E and V569del) through SF3B1-dependent splicing events 4. Dysregulation of MAP4K5 is linked to cancer malignancy, making it a potential therapeutic target 2. In acute myeloid leukemia, high MAP4K5 expression correlates with favorable overall survival 5. Additionally, a promoter polymorphism (-822G/A) may influence type 2 diabetes risk in certain populations 6.